Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Non-Current Assets (2016 - 2022)

Historic Non-Current Assets for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $32.5 million.

  • Avadel Pharmaceuticals' Non-Current Assets fell 4416.24% to $32.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $179.9 million, marking a year-over-year decrease of 1389.97%. This contributed to the annual value of $54.8 million for FY2021, which is 1368.12% up from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Non-Current Assets stood at $32.5 million for Q3 2022, which was down 4416.24% from $32.2 million recorded in Q2 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Non-Current Assets peaked at $121.1 million during Q3 2018, and registered a low of $32.2 million during Q2 2022.
  • For the 5-year period, Avadel Pharmaceuticals' Non-Current Assets averaged around $67.3 million, with its median value being $64.4 million (2020).
  • Data for Avadel Pharmaceuticals' Non-Current Assets shows a peak YoY increase of 12177.68% (in 2018) and a maximum YoY decrease of 4938.28% (in 2018) over the last 5 years.
  • Quarter analysis of 5 years shows Avadel Pharmaceuticals' Non-Current Assets stood at $65.4 million in 2018, then grew by 5.51% to $69.1 million in 2019, then crashed by 30.23% to $48.2 million in 2020, then rose by 13.68% to $54.8 million in 2021, then tumbled by 40.6% to $32.5 million in 2022.
  • Its Non-Current Assets stands at $32.5 million for Q3 2022, versus $32.2 million for Q2 2022 and $60.4 million for Q1 2022.